Cardiac Drug Development Guide outlines, in detail, the therapeutics of
cardiac medicine currently at the cutting edge of scientific research
and development around the world. This volume integrates basic and
clinical cardiac pharmacology by c- bining, for the first time, both
classical and molecular aspects of therapeutic drug development. The
chapters comprise a broad spectrum of therapeutic areas and hence
involve a comprehensive discussion of molecular, biochemical, and
electrophy- ological concepts based on years of in vitro as well as in
vivo pharmacological st- ies. In addition, the latter part of the book
includes comprehensive clinical cardiac chapters that describe important
topics in molecular medicine. These chapters also discuss current
clinical therapeutic trends in medicine and provide an evaluation of the
efficacy of novel drugs in these areas. Cardiac Drug Development Guide
has many distinctive and outstanding features that set it apart from
other cardiac pharmacology books. This book introduces topics in an
easily understandable format for researchers in many varying disciplines
by integrating and thereby simplifying concepts not usually discussed
across a broad range of cardiac disciplines and in a highly technical
field. Each chapter not only introduces and describes the physiology,
pharmacology, and pathophysiology of the disease, but also overviews the
clinical implications of drug development, what stages these areas are
currently in, and also reviews some of the methodologies involved in
drug discovery and development. As a result, this book provides a
comprehensive overview of the most advanced procedures in cardiac
pharmacology today.
